Why Seattle Genetics is holding strong This biotechnology company is primarily focused on developing and commercializing therapies targeted for the treatment of cancer. This company has a huge cash flow and let's not all forget that cancer will still be around long after covid-19. We still need companies to produce these cancer drugs.
Its estimated that in 2020 606,200 people will die alone from cancer in USA alone.